Cargando…
Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims
BACKGROUND: In X-linked myotubular myopathy (XLMTM), mutations in the MTM1 gene result in absence or dysfunction of myotubularin, a protein required for normal development, maintenance, and function of skeletal muscle. Extreme muscle weakness results in severe respiratory failure that is fatal for a...
Autores principales: | Sacks, Naomi C, Healey, Bridget E, Cyr, Philip L, Slocomb, Theodore, James, Emma, Beggs, Alan H, Graham, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394177/ https://www.ncbi.nlm.nih.gov/pubmed/33843254 http://dx.doi.org/10.18553/jmcp.2021.20501 |
Ejemplares similares
-
Estimation of the Quality-of-Life Impact of X-Linked Myotubular Myopathy
por: Lloyd, Andrew, et al.
Publicado: (2021) -
A natural history study of X-linked myotubular myopathy
por: Amburgey, Kimberly, et al.
Publicado: (2017) -
Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States
por: Graham, Robert J., et al.
Publicado: (2023) -
Clinical Phenotype of X‐Linked Myotubular Myopathy in Labrador Retriever Puppies
por: Snead, E.C.R., et al.
Publicado: (2015) -
Arrhythmias in patients with X-linked myotubular myopathy
por: Pons-Espinal, Marina, et al.
Publicado: (2023)